A cure for Covid? Israeli team claims new drug has 96% success rate

Researchers at Tel Aviv’s biggest hospital, Ichilov, are reporting what could be a major game-changer in the fight against the Covid-19 virus — a drug which is curing corona patients with a 96 per cent success rate.

Thirty patients who were suffering from moderate or serious levels of Corona were given the new EXO-CD24 drug, developed by Professor Nadir Arber from Ichilov’s Cancer Prevention Centre. Only one patient failed to respond: 29 others showed “a marked improvement” within two days of taking the new drug.

Professor Arber says the treatment is “effective and inexpensive.

The medicine is administered through inhalation, once a day, in a procedure that takes only a few minutes, for five days,”, he said.

The 29 who improved after taking the drug were able to leave hospital between three and five days later.

Now, Professor Ronni Gamzu, the former state coronavirus “czar”, who has returned to his role as chief executive of Ichilov, says he will personally assist Professor Arber in getting the green light from Israel’s Health Ministry in order to test the medication on a wider pool of patients. 

He said: “‘I’m proud that here at Ichilov we are among the world leaders in finding the cure for the horrible epidemic”.

A similar treatment has been announced by Hadassah Medical Centre in Jerusalem. In their trial, 21 patients in critical condition — who had underlying health conditions — received a drug called Allocetra. According to the doctors, 19 patients recovered within six days and were released from the hospital on average after eight days.

The drug was developed by Professor Dror Mevorach. director of Hadassah’s Research Centre for Rheumatology and Internal Medicine.